Nasdaq’s Post

View organization page for Nasdaq, graphic

470,474 followers

🎉 Welcome to the Nasdaq family, Tempus AI! 🎉 🤖 $TEM harnesses the power of data and AI to drive precision medicine forward. Now they’re officially #NasdaqListed!

Olufunmilayo (Funmi) Olopade

Director, Center for Clinical Cancer Genetics

3w

This is truly amazing and wonderful to see a Chicago biotech startup make it to this Milestone. Really proud of all the partners and patients who made this possible. Now, the race begins to get to #fastercures and ending cancer as we know it! Congratulations

Sabrina Runbeck, MPH, MHS, PA-C

Help healthcare entrepreneurs gain visibility & credibility in the right circles to accelerate their mission+profitability | HealthTech Broker | Human Capital Amplifier | Podcaster | Board Advisor | Author

17h

Thank you for sharing, Heather Pilar Cunha Davis! Nasdaq, what upcoming innovations do you foresee making a significant impact in the field of precision medicine? Also, how do you envision Tempus AI's listing influencing the broader landscape of AI-driven healthcare solutions?

Like
Reply

Congratulations to the Tempus AI team!

Like
Reply
Lavanya Saripalli (She/her) MS MBA PMP

Healthcare Technology Entrepreneur, Product Innovator , Start-up Advisor, Founder, and CEO at ONCOGENOME Analytics, LLC

3w

Proud of Tempus Team.

Like
Reply
Natasha Khrystolubova

BPharm, BCOP. GradCert In Precision Medicine.Director of Pharmacy Clinical Services at RxToGo Pharmacy, Florida Cancer Specialists. Expertise: Medically Integrated Pharmacy/Strategic Planning/Precision Medicine

3w

Bruno Lemos, PhD!!! Congratulations to you and your company.

See more comments

To view or add a comment, sign in

Explore topics